Jeffrey W. Sherman, M.D., FACP
2021
Compensation breakdown
| Non-Equity Incentive Plan | $891,963 |
|---|---|
| Salary | $598,931 |
| Stock Awards | $4,218,190 |
| Other | $155,299 |
| Total | $5,864,383 |
FACP received $4.2M in stock awards, accounting for 72% of the total pay in 2021.
FACP also received $892K in non-equity incentive plan, $598.9K in salary and $155.3K in other compensation.
Rankings
In 2021, Jeffrey W. Sherman, M.D., FACP's compensation ranked 2,160th out of 12,415 executives tracked by ExecPay. In other words, FACP earned more than 82.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,160 out of 12,415 | 83rd |
Division Manufacturing | 838 out of 5,505 | 85th |
Major group Chemicals And Allied Products | 321 out of 2,375 | 87th |
Industry group Drugs | 277 out of 2,096 | 87th |
Industry Pharmaceutical Preparations | 179 out of 1,546 | 88th |
Pay ratio
| Jeffrey W. Sherman, M.D., FACP's Pay | $5,864,383 |
|---|---|
| Median Employee's Pay | $298,200 |
| Pay Ratio | 20to 1 |
In 2021, the annual total compensation of Jeffrey W. Sherman, M.D., FACP was $5,864,383.
The annual total compensation of the median employee at Horizon Pharma was $298,200.
The ratio of Jeffrey W. Sherman, M.D., FACP's pay to the pay of median employee was therefore 20 to one.
FACP's colleagues
We found five more compensation records of executives who worked with Jeffrey W. Sherman, M.D., FACP at Horizon Pharma in 2021.
2021
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2021
Barry Moze
Horizon Pharma
Chief Administrative Officer
2021
Brian Beeler
Horizon Pharma
General Counsel
2021
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2021
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019